These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1154 related articles for article (PubMed ID: 3719568)

  • 21. Differentiating human leukemia cells express heparanase that degrades heparan sulfate in subendothelial extracellular matrix.
    Yahalom J; Fibach E; Bar-Tana R; Fuks Z; Vlodavsky I
    Leuk Res; 1988; 12(9):711-7. PubMed ID: 2973542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombin enhances degradation of heparan sulfate in the extracellular matrix by tumor cell heparanase.
    Benezra M; Vlodavsky I; Bar-Shavit R
    Exp Cell Res; 1992 Jul; 201(1):208-15. PubMed ID: 1612123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines.
    Nakajima M; Irimura T; Di Ferrante D; Di Ferrante N; Nicolson GL
    Science; 1983 May; 220(4597):611-3. PubMed ID: 6220468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides.
    Miao HQ; Elkin M; Aingorn E; Ishai-Michaeli R; Stein CA; Vlodavsky I
    Int J Cancer; 1999 Oct; 83(3):424-31. PubMed ID: 10495437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes.
    Hoogewerf AJ; Leone JW; Reardon IM; Howe WJ; Asa D; Heinrikson RL; Ledbetter SR
    J Biol Chem; 1995 Feb; 270(7):3268-77. PubMed ID: 7852412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Degranulating mast cells secrete an endoglycosidase that degrades heparan sulfate in subendothelial extracellular matrix.
    Bashkin P; Razin E; Eldor A; Vlodavsky I
    Blood; 1990 Jun; 75(11):2204-12. PubMed ID: 1693299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoselection of GRP94/endoplasmin from a KNRK cell-specific lambda gt11 library using antibodies directed against a putative heparanase amino-terminal peptide.
    De Vouge MW; Yamazaki A; Bennett SA; Chen JH; Shwed PS; Couture C; Birnboim HC
    Int J Cancer; 1994 Jan; 56(2):286-94. PubMed ID: 8314313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternatively spliced Spalax heparanase inhibits extracellular matrix degradation, tumor growth, and metastasis.
    Nasser NJ; Avivi A; Shafat I; Edovitsky E; Zcharia E; Ilan N; Vlodavsky I; Nevo E
    Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2253-8. PubMed ID: 19164514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationships between heparanase activity and increasing metastatic potential of fibroblasts transfected with various oncogenes.
    Schwarz LC; Inoue T; Irimura T; Damen JE; Greenberg AH; Wright JA
    Cancer Lett; 1990 Jun; 51(3):187-92. PubMed ID: 2350761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation.
    Vlodavsky I; Eldor A; Haimovitz-Friedman A; Matzner Y; Ishai-Michaeli R; Lider O; Naparstek Y; Cohen IR; Fuks Z
    Invasion Metastasis; 1992; 12(2):112-27. PubMed ID: 1399400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of experimental metastasis and extracellular matrix degradation by butanol extracts from B16-F1 murine melanoma.
    Keren Z; Leland F; Nakajima M; LeGrue SJ
    Cancer Res; 1989 Jan; 49(2):295-300. PubMed ID: 2910449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties.
    Lapierre F; Holme K; Lam L; Tressler RJ; Storm N; Wee J; Stack RJ; Castellot J; Tyrrell DJ
    Glycobiology; 1996 Apr; 6(3):355-66. PubMed ID: 8724143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix.
    Bar-Ner M; Mayer M; Schirrmacher V; Vlodavsky I
    J Cell Physiol; 1986 Aug; 128(2):299-306. PubMed ID: 2426287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammalian heparanase as mediator of tumor metastasis and angiogenesis.
    Vlodavsky I; Elkin M; Pappo O; Aingorn H; Atzmon R; Ishai-Michaeli R; Aviv A; Pecker I; Friedmann Y
    Isr Med Assoc J; 2000 Jul; 2 Suppl():37-45. PubMed ID: 10909416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of heparanase in platelet and tumor cell interactions with the subendothelial extracellular matrix.
    Eldor A; Bar-Ner M; Yahalom J; Fuks Z; Vlodavsky I
    Semin Thromb Hemost; 1987 Oct; 13(4):475-88. PubMed ID: 3321438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis.
    Vlodavsky I; Friedmann Y; Elkin M; Aingorn H; Atzmon R; Ishai-Michaeli R; Bitan M; Pappo O; Peretz T; Michal I; Spector L; Pecker I
    Nat Med; 1999 Jul; 5(7):793-802. PubMed ID: 10395325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suramin. A potent inhibitor of melanoma heparanase and invasion.
    Nakajima M; DeChavigny A; Johnson CE; Hamada J; Stein CA; Nicolson GL
    J Biol Chem; 1991 May; 266(15):9661-6. PubMed ID: 2033058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins.
    Hostettler N; Naggi A; Torri G; Ishai-Michaeli R; Casu B; Vlodavsky I; Borsig L
    FASEB J; 2007 Nov; 21(13):3562-72. PubMed ID: 17557930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-speed gel-permeation chromatography of glycosaminoglycans: its application to the analysis of heparan sulfate of embryonic carcinoma and its degradation products by tumor cell-derived heparanase.
    Irimura T; Nakajima M; Di Ferrante N; Nicolson GL
    Anal Biochem; 1983 Apr; 130(2):461-8. PubMed ID: 6223541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substrate specificity of heparanases from human hepatoma and platelets.
    Pikas DS; Li JP; Vlodavsky I; Lindahl U
    J Biol Chem; 1998 Jul; 273(30):18770-7. PubMed ID: 9668050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.